Renaissance Technologies’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.8M | Buy |
1,532,300
+174,600
| +13% | +$3.63M | 0.05% | 455 |
|
|
2025
Q4 | $29M | Buy |
1,357,700
+51,700
| +4% | +$1.06M | 0.05% | 461 |
|
|
2025
Q3 | $21.9M | Buy |
1,306,000
+102,100
| +8% | +$1.53M | 0.03% | 682 |
|
|
2025
Q2 | $17.3M | Sell |
1,203,900
-17,100
| -1% | -$234K | 0.02% | 776 |
|
|
2025
Q1 | $17.7M | Buy |
1,221,000
+382,200
| +46% | +$5.43M | 0.03% | 710 |
|
|
2024
Q4 | $11M | Buy |
838,800
+453,000
| +117% | +$6.25M | 0.02% | 960 |
|
|
2024
Q3 | $4.47M | Sell |
385,800
-28,200
| -7% | -$266K | 0.01% | 1520 |
|
|
2024
Q2 | $3.13M | Sell |
414,000
-20,300
| -5% | -$168K | 0.01% | 1587 |
|
|
2024
Q1 | $4.36M | Buy |
434,300
+77,000
| +22% | +$716K | 0.01% | 1501 |
|
|
2023
Q4 | $3.32M | Buy |
357,300
+309,100
| +641% | +$3.2M | 0.01% | 1617 |
|
|
2023
Q3 | $613K | Sell |
48,200
-5,100
| -10% | -$70K | ﹤0.01% | 2626 |
|
|
2023
Q2 | $757K | Sell |
53,300
-55,900
| -51% | -$785K | ﹤0.01% | 2646 |
|
|
2023
Q1 | $1.63M | Buy |
+109,200
| New | +$1.65M | ﹤0.01% | 2151 |
|
|
2022
Q3 | – | Sell |
-140,200
| Closed | -$2.95M | – | 4271 |
|
|
2022
Q2 | $2.95M | Sell |
140,200
-185,600
| -57% | -$3.79M | ﹤0.01% | 1916 |
|
|
2022
Q1 | $7.65M | Buy |
325,800
+205,600
| +171% | +$5.03M | 0.01% | 1307 |
|
|
2021
Q4 | $3.27M | Sell |
120,200
-98,500
| -45% | -$2.64M | ﹤0.01% | 1803 |
|
|
2021
Q3 | $6.22M | Sell |
218,700
-92,600
| -30% | -$2.82M | 0.01% | 1329 |
|
|
2021
Q2 | $9.39M | Buy |
+311,300
| New | +$9.19M | 0.01% | 1220 |
|
|
2021
Q1 | – | Sell |
-206,400
| Closed | -$5.07M | – | 3551 |
|
|
2020
Q4 | $5.07M | Sell |
206,400
-209,100
| -50% | -$3.93M | 0.01% | 1573 |
|
|
2020
Q3 | $6.76M | Buy |
415,500
+61,600
| +17% | +$1.15M | 0.01% | 1392 |
|
|
2020
Q2 | $6.05M | Sell |
353,900
-129,511
| -27% | -$1.92M | 0.01% | 1521 |
|
|
2020
Q1 | $5.63M | Sell |
483,411
-413,259
| -46% | -$8.52M | 0.01% | 1494 |
|
|
2019
Q4 | $24.9M | Buy |
896,670
+171,370
| +24% | +$4.3M | 0.02% | 886 |
|
|
2019
Q3 | $16.4M | Sell |
725,300
-31,100
| -4% | -$709K | 0.01% | 1074 |
|
|
2019
Q2 | $19.1M | Buy |
756,400
+49,700
| +7% | +$1.34M | 0.02% | 987 |
|
|
2019
Q1 | $19.2M | Buy |
706,700
+214,500
| +44% | +$7.19M | 0.02% | 996 |
|
|
2018
Q4 | $16.2M | Sell |
492,200
-85,000
| -15% | -$3.42M | 0.02% | 1014 |
|
|
2018
Q3 | $26.9M | Buy |
577,200
+408,577
| +242% | +$18.8M | 0.03% | 744 |
|
|
2018
Q2 | $7.3M | Buy |
+168,623
| New | +$8.08M | 0.01% | 1547 |
|
|
2016
Q3 | – | Sell |
-252,200
| Closed | -$18.3M | – | 3432 |
|
|
2016
Q2 | $18.3M | Sell |
252,200
-189,400
| -43% | -$13M | 0.03% | 752 |
|
|
2016
Q1 | $28.5M | Buy |
+441,600
| New | +$29.3M | 0.05% | 468 |
|
|
2015
Q3 | – | Sell |
-371,000
| Closed | -$27.5M | – | 3279 |
|
|
2015
Q2 | $27.5M | Sell |
371,000
-89,300
| -19% | -$6.43M | 0.06% | 382 |
|
|
2015
Q1 | $33.4M | Buy |
460,300
+107,000
| +30% | +$7.44M | 0.07% | 364 |
|
|
2014
Q4 | $23.4M | Sell |
353,300
-46,500
| -12% | -$2.84M | 0.06% | 431 |
|
|
2014
Q3 | $21.9M | Buy |
399,800
+370,100
| +1,246% | +$21M | 0.06% | 410 |
|
|
2014
Q2 | $1.73M | Buy |
29,700
+24,700
| +494% | +$1.45M | ﹤0.01% | 1797 |
|
|
2014
Q1 | $310K | Buy |
+5,000
| New | +$291K | ﹤0.01% | 2513 |
|
Other funds holding MD
VPM
VCM
WA
Renaissance Technologies's MD Position: Q1 2026 in Review
Renaissance Technologies increased its Pediatrix Medical (MD) stake by 13% in Q1 2026, buying an estimated $3.63M and bringing the position to 1,532,300 shares worth $32.8M. The position accounts for 0.05% of the portfolio, ranked #455.
Renaissance Technologies first reported a position in MD in Q1 2014 and has held it in 37 quarters since. The position peaked at $33.4M in Q1 2015. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Renaissance Technologies held 1,532,300 shares of Pediatrix Medical worth $32.8M as of Q1 2026.
- Renaissance Technologies bought 174,600 Pediatrix Medical shares in Q1 2026, an estimated $3.63M.
- Pediatrix Medical made up 0.05% of Renaissance Technologies's portfolio in Q1 2026, its #455 holding.
- Renaissance Technologies first reported a position in Pediatrix Medical in Q1 2014 and has held it in 37 quarters since.
- Renaissance Technologies's Pediatrix Medical position peaked at $33.4M in Q1 2015.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.